Mateon Achieves Milestone in its Development of OT-101, a Phase 3 Clinical Drug Candidate, Against COVID-19

by NASDAQ Market News April 6, 2020

NASDAQ Market News
Click here to email author

GSK and Vir Biotechnology enter collaboration to find coronavirus solutions

IMMUNOMEDICS ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AND THE APPOINTMENT OF HAROUT SEMERJIAN AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

Ads